6533b7d2fe1ef96bd125f6bd
RESEARCH PRODUCT
Postnatal Deletion of Numb/Numblike Reveals Repair and Remodeling Capacity in the Subventricular Neurogenic Niche
José Manuel García-verdugoMladen-roko RasinJie ShenZaman MirzadehArturo Alvarez-buyllaMario Soriano-navarroLily Yeh JanDenan WangYuh Nung JanChay T. KuoNenad Sestansubject
MaleEpendymal Cellanimal diseasesSubventricular zoneMice TransgenicNerve Tissue ProteinsCell CommunicationBiologyArticleGeneral Biochemistry Genetics and Molecular BiologyNestinMice03 medical and health sciences0302 clinical medicineIntermediate Filament ProteinsNeuroblastEpendymaLateral VentriclesmedicineAnimals030304 developmental biologyNeuronsGenetics0303 health sciencesIntegrasesBiochemistry Genetics and Molecular Biology(all)Stem CellsNeurogenesisIntracellular Signaling Peptides and ProteinsBrainMembrane ProteinsEmbryonic stem cellNeural stem cellCell biologyMice Inbred C57BLmedicine.anatomical_structureAnimals Newbornnervous systemNUMBFemaleStem cellGene Deletion030217 neurology & neurosurgerydescription
Neural stem cells are retained in the postnatal subventricular zone (SVZ), a specialized neurogenic niche with unique cytoarchitecture and cell-cell contacts. Although the SVZ stem cells continuously regenerate, how they and the niche respond to local changes is unclear. Here we generated nestin-creERtm transgenic mice with inducible Cre recombinase in the SVZ, and removed Numb/Numblike, key regulators of embryonic neurogenesis from postnatal SVZ progenitors and ependymal cells. This resulted in severe damage to brain lateral ventricle integrity, and identified previously unknown roles for Numb/Numblike in regulating ependymal wall integrity and SVZ neuroblast survival. Surprisingly, the ventricular damage was eventually repaired: SVZ reconstitution and ventricular wall remodeling were mediated by progenitors that escaped Numb deletion. Our results show a self-repair mechanism in the mammalian brain, and may have implications for niche plasticity in other areas of stem cell biology, and for the therapeutic use of neural stem cells in neurodegenerative diseases.
year | journal | country | edition | language |
---|---|---|---|---|
2006-12-01 | Cell |